Ila M. Saunders

636 total citations
47 papers, 360 citations indexed

About

Ila M. Saunders is a scholar working on Oncology, Hematology and Geriatrics and Gerontology. According to data from OpenAlex, Ila M. Saunders has authored 47 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 11 papers in Hematology and 8 papers in Geriatrics and Gerontology. Recurrent topics in Ila M. Saunders's work include Pharmaceutical Practices and Patient Outcomes (8 papers), Multiple Myeloma Research and Treatments (6 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). Ila M. Saunders is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (8 papers), Multiple Myeloma Research and Treatments (6 papers) and Venous Thromboembolism Diagnosis and Management (6 papers). Ila M. Saunders collaborates with scholars based in United States and Netherlands. Ila M. Saunders's co-authors include Aaron M. Goodman, Razelle Kurzrock, Mina Nikanjam, Mark T. Lin, Dennis John Kuo, Edmund V. Capparelli, Jonathan H. Watanabe, Isaac Cohen, Roy F. Chemaly and Keith Burkhart and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ila M. Saunders

42 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ila M. Saunders United States 12 112 75 74 69 46 47 360
Amber B. Clemmons United States 12 91 0.8× 59 0.8× 71 1.0× 31 0.4× 35 0.8× 38 326
Justin Arnall United States 12 75 0.7× 30 0.4× 113 1.5× 25 0.4× 38 0.8× 46 333
E De Cock United Kingdom 15 172 1.5× 37 0.5× 78 1.1× 54 0.8× 34 0.7× 50 571
George J Joseph United States 15 40 0.4× 86 1.1× 147 2.0× 51 0.7× 41 0.9× 25 537
Benyam Muluneh United States 12 129 1.2× 44 0.6× 70 0.9× 36 0.5× 93 2.0× 58 458
Namita Tundia United States 14 43 0.4× 46 0.6× 106 1.4× 65 0.9× 37 0.8× 40 621
Filiz Çay Şenler Türkiye 10 202 1.8× 30 0.4× 25 0.3× 44 0.6× 35 0.8× 40 417
Diana Sun United States 11 85 0.8× 58 0.8× 68 0.9× 45 0.7× 53 1.2× 34 600
Luz-Ma-Adriana Balderas-Peña Mexico 13 140 1.3× 32 0.4× 21 0.3× 129 1.9× 32 0.7× 41 630
Marie‐Pierre Desrosiers United States 8 46 0.4× 26 0.3× 131 1.8× 89 1.3× 45 1.0× 15 491

Countries citing papers authored by Ila M. Saunders

Since Specialization
Citations

This map shows the geographic impact of Ila M. Saunders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ila M. Saunders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ila M. Saunders more than expected).

Fields of papers citing papers by Ila M. Saunders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ila M. Saunders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ila M. Saunders. The network helps show where Ila M. Saunders may publish in the future.

Co-authorship network of co-authors of Ila M. Saunders

This figure shows the co-authorship network connecting the top 25 collaborators of Ila M. Saunders. A scholar is included among the top collaborators of Ila M. Saunders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ila M. Saunders. Ila M. Saunders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bounthavong, Mark, et al.. (2025). Evaluation of pharmacist-led management of type 2 diabetes using personal continuous glucose monitors across a large tertiary academic health system. Journal of the American Pharmacists Association. 65(4). 102397–102397.
2.
3.
Costello, Caitlin, et al.. (2024). Real-world outcomes of teclistamab for the treatment of relapsed/refractory multiple myeloma at UC San Diego Health: A single-institution experience.. Journal of Clinical Oncology. 42(16_suppl). e19504–e19504. 2 indexed citations
4.
Abdul‐Mutakabbir, Jacinda C., et al.. (2024). Development and implementation of the ASHP Midyear Travel Award to support racially and ethnically minoritized pharmacy students. American Journal of Health-System Pharmacy. 82(6). 257–264.
5.
Morello, Candis M., et al.. (2024). Prescription for Success: Cultivating Wellbeing in the Academic Pharmacy Community at UC San Diego SSPPS. American Journal of Pharmaceutical Education. 88(9). 101182–101182. 1 indexed citations
6.
Lo, Mimi, Rebecca Young, Ila M. Saunders, et al.. (2023). Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myeloma. Journal of Oncology Pharmacy Practice. 29(7). 1715–1724. 1 indexed citations
7.
8.
Khan, Fatima, et al.. (2023). Characterization of direct oral anticoagulants use in adult hematopoietic stem cell transplant recipients. Journal of Thrombosis and Thrombolysis. 57(2). 293–301.
9.
10.
Saunders, Ila M., Amy M. Pick, & Kelly C. Lee. (2023). Grit, Subjective Happiness, Satisfaction With Life, and Academic Resilience Among Pharmacy and Physical Therapy Students at Two Universities. American Journal of Pharmaceutical Education. 87(10). 100041–100041. 6 indexed citations
11.
Abdul‐Mutakabbir, Jacinda C., Elizabeth B. Hirsch, Taison D. Bell, et al.. (2022). A call to action: A need for initiatives that increase equitable access to COVID-19 therapeutics. The Lancet Regional Health - Americas. 11. 100263–100263. 8 indexed citations
12.
Chan, Kelly, et al.. (2022). Effects of financial toxicity on prescription drug use and mental well-being in cancer patients. SHILAP Revista de lepidopterología. 6. 100136–100136. 7 indexed citations
13.
Gonsalves, Wilson I., et al.. (2022). Estimation of Kidney Function in Patients With Multiple Myeloma: Implications for Lenalidomide Dosing. Annals of Pharmacotherapy. 57(1). 29–35. 1 indexed citations
14.
Saunders, Ila M., et al.. (2021). FMS-Like Tyrosine Kinase 3 Inhibitors for the Treatment of Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 22(3). e161–e184. 13 indexed citations
15.
Lee, Angela, et al.. (2021). Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors. Thrombosis Research. 208. 148–155. 15 indexed citations
16.
Awdishu, Linda, Renu Singh, Ila M. Saunders, et al.. (2019). Advancing Pharmacist Collaborative Care within Academic Health Systems. SHILAP Revista de lepidopterología. 7(4). 142–142. 15 indexed citations
17.
Goodman, Aaron M., Shumei Kato, Ranajoy Chattopadhyay, et al.. (2019). Phenotypic and Genomic Determinants of Immunotherapy Response Associated with Squamousness. Cancer Immunology Research. 7(6). 866–873. 22 indexed citations
18.
Nikanjam, Mina, et al.. (2019). Population pharmacokinetic analysis of high-dose methotrexate in pediatric and adult oncology patients. Cancer Chemotherapy and Pharmacology. 84(6). 1339–1348. 39 indexed citations
19.
20.
Saliba, Rima M., Katayoun Rezvani, Ann M. Leen, et al.. (2015). General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation. Biology of Blood and Marrow Transplantation. 21(7). 1284–1290. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amber B. Clemmons Breakdown of academic impact, for papers by Justin Arnall Breakdown of academic impact, for papers by E De Cock Breakdown of academic impact, for papers by George J Joseph Breakdown of academic impact, for papers by Benyam Muluneh Breakdown of academic impact, for papers by Namita Tundia Breakdown of academic impact, for papers by Filiz Çay Şenler Breakdown of academic impact, for papers by Diana Sun Breakdown of academic impact, for papers by Luz-Ma-Adriana Balderas-Peña Breakdown of academic impact, for papers by Marie‐Pierre Desrosiers
Rankless by CCL
2026